Identify the best sites. Engage the right patients. Accelerate every trial.
Runestone helps clinical research organizations and trial sponsors strengthen feasibility, prioritize sites, and support patient activation, using aggregated, governed intelligence and site-approved workflows. Nothing reaches a site until the site approves it.
Predictive Site & Patient Intelligence
Before the Bid
Aggregated feasibility and population signal to strengthen proposals.
Site Selection & Activation
A ranked, validated site universe with clear rationale.
Site-Approved Patient Activation
Eligibility translated into site-approved targeting workflows.
“Momentus has fundamentally changed the way I look at industry data and understand doctor behavior with real-time insights.”
One of the largest, most trusted ophthalmic datasets.
Built through our data partnerships on one of the broadest governed eye-care intelligence networks in the U.S.
- 80M+ de-identified patient records
- 29K+ contributing providers
- Broad U.S. vision-care site coverage across clinical and commercial care settings
Site and patient intelligence for the full trial lifecycle
Runestone brings Viking's specialty healthcare intelligence into clinical research. From the bid stage through active enrollment, it helps teams answer the questions that decide whether a trial succeeds: where are the eligible patients, which sites can deliver, and how do we activate them responsibly? Runestone supports the process, it does not bypass it.
Key Capabilities
Who it's for
Contract research organizations (CROs), trial sponsors, and clinical operations teams running site selection, feasibility, and patient recruitment.
Why it's different
Most feasibility relies on historical site performance and self-reported data. Runestone adds aggregated, real-world intelligence and a site-approved activation model. Site selection carries less risk, patient identification moves faster, and activation stays inside each site's governance.
How It Works
Feasibility & Bid Support
Before a study is awarded, Runestone surfaces aggregated, region-level estimates of eligible patient populations and candidate site density, packaged into feasibility summaries a research team can bring directly into a bid or proposal.
Site Selection & Activation
Once a study moves forward, Runestone delivers a ranked site universe: proven sites validated against real-world performance and patient signal, plus expansion sites beyond the existing network, with clear, data-informed rationale for each.
Site-Approved Patient Activation
Eligibility criteria are translated into governed targeting logic and a documented activation workflow that each participating site reviews and approves. All patient activation flows through the site's approved process.
The platform behind Runestone
Runestone is a purpose-built application of Momentus, Viking's decision-intelligence platform. Research teams get tools for feasibility, site selection, and patient activation, grounded in the same governed, aggregated intelligence that powers Viking's commercial products.
Governed by design
Aggregated signal, protected sources, and site approval at every patient-facing step.
Documented methodology
Findings labeled as observed, modeled, or inferred, so teams know how much to lean on them.
Human plus AI
Viking's analysts apply the platform's methods, so every output is reviewed, not just generated.